USRM

U.S. Stem Cell, Inc. USRM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode USRM DNAG IPAH AVXT LADX MOBO REFG BRAXF MHTX MRPI
6M -50.00 % 0.00 % 0.00 % 0.00 % -92.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 %
YTD 0.00 % 900.00 % 0.00 % 0.00 % -93.91 % 0.00 % 0.00 % -14.67 % -88.89 % 0.00 %
1Y 0.00 % 900.00 % 0.00 % 0.00 % -93.48 % 0.00 % 0.00 % -14.67 % -87.50 % 0.00 %
3Y -97.92 % 900.00 % 409 900.00 % -90.00 % -99.30 % -99.41 % -92.86 % -94.72 % -99.00 % 0.00 %
5Y -98.63 % -99.00 % 409 900.00 % -99.44 % -99.89 % -99.50 % -99.61 % -99.82 % -99.75 % -99.20 %
10Y -99.99 % -99.00 % 40 900.00 % -99.95 % -99.99 % -99.89 % -99.82 % -99.46 % -99.85 % -50.00 %
From the beginning -100.00 % -100.00 % -82.77 % -100.00 % -100.00 % -99.97 % -99.96 % -99.46 % -100.00 % -99.90 %

Dividend

LadRx Corporation